ÂÜŔňÂŇÂ×

Greg Nulty is the Chief Executive Officer at Performance Health, a leader in consumer healthcare and the largest global manufacturer and distributor of products to the physical therapy, sports medicine, and rehabilitation markets. Greg has spent the past 16 years with Novartis Group, most recently serving as CFO of Sandoz’s nearly $4 billion North America business in Princeton, NJ since 2016. Prior to this, Greg was the head of Business Planning and Analysis for Sandoz globally from 2013 – 2016 in Munich, Germany, and between 2011 and 2013, he served as CFO of Sandoz’s Asia Pacific based in Singapore. Prior to this, Greg served as head of Business Planning and Analysis globally at Novartis’s Consumer Health division from 2009- 2011, after serving as CFO of Western Europe for Sandoz from 2005-2007. Greg began his career with Novartis as a senior controller. Prior to joining Novartis, he worked in corporate finance with Andersen and as an Auditor with Ernst & Young, both in his native South Africa, as well as with Merrill Lynch in London. Greg received his MBA from INSEAD and holds a Bachelor’s degree in Commerce from the University of Cape Town, where he graduated with high distinction.